Global burden of human papillomavirus and related diseases

D Forman, C de Martel, CJ Lacey, I Soerjomataram… - Vaccine, 2012 - Elsevier
The worldwide prevalence of infection with human papillomavirus (HPV) in women without
cervical abnormalities is 11–12% with higher rates in sub-Saharan Africa (24%), Eastern …

[HTML][HTML] Systematic review of the incidence and prevalence of genital warts

H Patel, M Wagner, P Singhal, S Kothari - BMC infectious diseases, 2013 - Springer
Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical …

CL Trimble, MP Morrow, KA Kraynyak, X Shen… - The Lancet, 2015 - thelancet.com
Background Despite preventive vaccines for oncogenic human papillomaviruses (HPVs),
cervical intraepithelial neoplasia (CIN) is common, and current treatments are ablative and …

[HTML][HTML] Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)

LE Markowitz, EF Dunne, M Saraiya, HW Chesson… - MMWR Recomm …, 2014 - cdc.gov
This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males-Advisory Committee on Immunization Practices (ACIP), 2011.

Centers for Disease Control and … - MMWR: Morbidity & …, 2011 - search.ebscohost.com
Abstract On October 25, 2011, the Advisory Committee on Immunization Practices (ACIP)
recommended routine use of quadrivalent human papillomavirus (HPV) vaccine (HPV4; …

Human papillomavirus and genital warts: a review of the evidence for the 2015 centers for disease control and prevention sexually transmitted diseases treatment …

IU Park, C Introcaso, EF Dunne - Clinical Infectious Diseases, 2015 - academic.oup.com
To provide updates for the 2015 Centers for Disease Control and Prevention sexually
transmitted diseases treatment guidelines on human papillomavirus (HPV) and anogenital …

EUROGIN 2011 roadmap on prevention and treatment of HPV‐related disease

M Arbyn, S De Sanjosé, M Saraiya… - … journal of cancer, 2012 - Wiley Online Library
The EUROGIN 2011 roadmap reviews the current burden of human papillomavirus (HPV)‐
related morbidity, as well as the evidence and potential practice recommendations …

HPV and HPV-associated diseases

EF Dunne, IU Park - Infectious Disease Clinics, 2013 - id.theclinics.com
Background Papillomaviruses are a family of DNA viruses that infect the epithelium and
have a double-stranded, closed, circular genome of approximately 8 kb and a …

Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States

HW Chesson, DU Ekwueme, M Saraiya, M Watson… - Vaccine, 2012 - Elsevier
Estimates of the direct medical costs attributable to human papillomavirus (HPV) can help to
quantify the economic burden of HPV and to illustrate the potential benefits of HPV …

Estimated prevalence and incidence of disease-associated human papillomavirus types among 15-to 59-year-olds in the United States

RM Lewis, JF Laprise, JW Gargano… - Sexually transmitted …, 2021 - journals.lww.com
Methods Prevalence and incidence were estimated for infections with any HPV (any of 37
types detected using Linear Array) and disease-associated HPV, 2 types that cause …